June 2009
 EXPERIENTIAL EXPOSÉ

PUSH OR PULL? LET'S ASK SOME QUESTIONS

 Doctor Contact

Determining where to allocate your marketing dollars is in large part a function of determining which influence-points most heavily weigh on your consumer's purchase decision.  So, to start your spending allocation process begin by determining if channel partners and retailers - and in the case of pharmaceutical companies, physicians- are pushing product into the hands of our consumers or, alternatively, if customers are pulling demand through the channel.  Push or Pull? 
 
Adept pharmaceutical marketing leaders are evaluating purchase decision challenges every day, asking, "Are physicians defining product options for patients, aware that they are now highly informed with internet research, or are patients the ones pulling prescription demand through my channel by asking physicians for specific symptom treatments? In either case, do physicians really care about or value the suggestions of patients?  And if so, how do I best inform physicians about my compound's efficacy and differentiate from branded competitors, generics and OTCs?"  As you can imagine, the answer impacts how you allocate your marketing and sales support dollars.  Given that resources - not to mention your product's lifecycle - are limited, every dollar you allocate to your marketing mix is critical.  Getting it right means market share.  Getting it wrong can result in a very costly mistake.  Push or Pull.  Start with this simple evaluation.
 
Know how purchasing decisions regarding your products are made
 
To help determine points of influence during the product evaluation process and consumer procurement effort we define the consumer decision making process within a transaction map.  Mapping your brand impressions to purchasing decisions allows you to identify key influence points and flags competing branding messages.  Transaction maps are an effective tool allowing you to think about how to optimize your marketing mix by associating and focusing brand impact and marketing influence messages at critical junctures.
 
Think of the decision-making process a standard patient, your customer, goes through.  Like any consumer, he or she either receives a message prompting need (symptom relief) or awareness (condition) or exhibits a symptom/condition that prompts medical advice or treatment.  After doing a haphazard internet search to self-diagnose, he or she will visit a physician's office with their outstanding need nicely defined.  Will they actually pull demand of your product through the physician, resulting in a script?  Unless you are fortunate enough to be marketing a large scale retail or blockbuster drug we doubt it. , the consumer won't be pulling demand for your product.
 
Why? The research says it all: physicians may give lip service to the sanctity of the patient's input but, iin the end, the physician is making his or her own decision regarding prescriptions.  A recent study by the Tufts Center revealed that physicians only rely on medical education (67%), peer insight (43%) and payer policies (37%) in making script decisions.  dDirect information from pharmaceutical companies accounted for onlyabout 13% and patient input followed pharma company detailing.[1]  So if such findings match the hypothesis, where would you spend your marketing dollars?  Are you a large retail drug or mid market compound?  Map it.
 
[1] Tufts Center for the Study of Drug Development Outlook 2008
INCREASING THE SIZE OF THE PIE OR EATING SOMEONE ELSE'S PIE

Acuvue Trial
In the case of pharmaceutical marketers, broad marketing efforts increase both a patient's understanding of treatment options and an understanding of your brand's potential efficacy.  Given smaller marketing budgets, marketers are faced with the task of allocating resources between direct to consumer (DTC) campaigns or care provider education promotions (Detailing).  While detailing tends to focus on positioning a brand in relation to a competitive mix - in essence seeking to capture business from a competitor - DTC marketing seeks to increase the potential pool of patient options, thereby increasing the overall market size as new patients become aware of previously unknown options, an important consideration given increased restrictions on detailing and leave-behinds being imposed by oversight agencies.
 
ACUVUE's 2007 direct to consumer marketing campaign sought to introduce consumers to potential eye care and contact lens color options through a 50-week educational tour reaching 180 cities and driving qualified consumers to Wal-Mart Vision Centers.  UCG Marketing ran the national campaign and engaged over 350 visitors at each retail location, amounting to over 70,000 consumer interactions.  Did the educational effort work? 

Acuvue Bus

Leveraging awareness generated through our pre-promotion campaign and in-store announcements, we drove consumer expectations prior to on-site execution.  With an integrated web tool providing personalized online photos, tens of thousand of web site impressions were generated for tour stops and our campaign's healthcare providers converted over 25% of qualified participants into Wal-Mart optometrist appointments.  Of this strong pool of qualified participants, over half purchased lenses or related products. You be the judge.
 
Additionally, by tracking visitors on-site, evaluating usage patterns for our online demos and sorting through the conversions, we brought some focus to a completely new target demographic for ACUVUE. (We'll keep that nugget of insight between us and them, but similar results can be experienced by your company!) In a nutshell, the decision to allocate marketing dollars to a DTC campaign was the right one... it worked and, the numbers prove it.
IT'S HARD BEING A PHARMACEUTICAL MARKETER

Things to Remember When Supporting DTC Pharma Campaigns

MS&L Cot


1)  Adverse Events: We'll start with the obvious. Remember you are responsible for reporting adverse events as defined by your legal team and federal regulations.  Define a process and protocol to collect and submit any adverse event information.  Such information may include seemingly harmless statement such as those examples noted below:

  • Consumer approaching you and stating he had a stomach ache after trying your drug
  • "Nothing happened when I tried your prescription!"

2)  Have A Clear Voice: Clearly define the goal of your campaign and take the time to reflect your brand's "voice" in the scripted comments your Brand Ambassador's will be using.  Defining your brand's voice upfront provides for a consistent approach in interacting with consumers.  Once your voice is defined and your statements are crafted, decide who can deliver them.  This team will need to be trained on how best to deliver these missives while also being conscientious of how their actions and body language play a role in communicating. Have a clear list of allowed and not allowed actions and work through practice scenarios ahead of time.

3)  Know Who Says What: Sharing thoughts or opinions on the efficacy, usage or side effects of your drug or any competitors' products is a clear no-no. Unless there is a physician on your team, these statements are off limits. This means your team needs to understand their boundaries, understand the hierarchy of who can say what, and be equipped to move conversations in the appropriate direction.

4)  Determine Where to Find out More: Define sources from which your consumers may receive additional information, such as a specific web site, and have those sources at the ready. At a minimum a small card with a URL is helpful. Remember, if the consumer is looking for more information, you want him or her to look to you and not your competitors.

5)  Be Prepared for Media:  If your marketing team is approached by the media allow them to fully leverage the opportunity by arming them with an appropriate statement and detailed PR lead contact information.  Predefine an appropriate response that marketers and Brand Ambassadors can use should they be pressed by members of the public regarding the promotion, product, compound efficacy or your company. But make sure your team knows when to hand off to the folks who are trained to deal with these issues.
Issue 5
IN THIS ISSUE
Push or Pull?
Increasing the Size of the Pie or Eating Someone Else's Pie
It's Hard Being a Pharmaceutical Marketer

Join Our Mailing List 

UCG Marketing is a creative and innovative experiential marketing and promotions agency. We work closely with our clients large and small, to help create an emotional connection between their products and their customers, one that will transform customers from brand enthusiasts to brand loyalists! For more information please visit www.ucgmarketing.com or contact Glenn Morgan directly at gmorgan@ucgmarketing.com.  

           

Glenn Morgan

Vice President

UCG Marketing

566 Commonwealth Ave.

Mezzanine Level

Boston, MA 02215

P: (617) 713-3900

gmorgan@ucgmarketing.com

Jeff Frumin

President, CEO

UCG Marketing

19 Lafayette St.

7th Floor

New York, NY 10003

P: (212) 616-6329

jfrumin@ucgmarketing.com